# Exceptional Ventures

> Exceptional Ventures is a VC fund backing Health Care and Biotechnology. See 38 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 38
- Last investment: Mar 2026
- Lead investor: 8%
- Last fund: Jul 2022
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/exceptional-ventures
- Website: https://exceptional.ventures/

Exceptional Ventures is an early-stage venture capital firm that invests in entrepreneurs and businesses that improve people's lives. Founded in 2022 and is based in London, England.

## Contacts

5 contacts available for Exceptional Ventures. Shizune tracks 2 team members at Exceptional Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/exceptional-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.6M–$5.3M |
| Pre-Seed | $641k–$6.9M |
| Convertible Note | $1.3M–$3.7M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 11 | 29% |
| Biotechnology | 7 | 18% |
| Wellness | 5 | 13% |
| Personal Health | 4 | 11% |
| Food Processing | 3 | 8% |

48 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 15 | 39% |
| Pre-Seed | 9 | 24% |
| Convertible Note | 6 | 16% |
| Series A | 3 | 8% |
| Angel | 1 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 15 | 39% |
| Italy | 3 | 8% |
| United States | 3 | 8% |
| France | 1 | 3% |
| Belgium | 1 | 3% |

8 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Matt Cooper | Co-Founder and Executive Chairman | 1 | https://shizune.co/investors/profile/matt-cooper-d4c6 |
| Paolo Pio | Co-Founder and General Partner | 5 | https://shizune.co/investors/profile/paolo-pio |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Amatera | Amatera is a biotechnology research company that leverages the latest techniques in biotechnology, to create coffee varieties. Amatera urges to make coffee varieties more sustainable and climate resistant to fill that massive demand. Founded by Omar Dekkiche and Lucie Kriegshauser in 2022 and is located in Paris, France. | $7M | Seed | Mar 04, 2026 |  |
| Evaro | Evaro provides digital health integration to increase accessibility of pharmacy products. | $25M | Series A | Jan 26, 2026 |  |
| Gladys | Gladys is a revolutionary social care software platform set to transform the caregiving landscape through innovation, empowerment, and direct connections. With a commitment to cutting out intermediaries, Gladys brings local carers, helpers, and families together in a seamless digital ecosystem. Led by a seasoned co-founding team with extensiveexperience in the sector, Gladys is uniquely positioned to address the challenges faced by the social care industry. As a female-led tech business based in the UK, Gladys is dedicated to driving change, simplifying processes, and enhancing the quality of care provided to vulnerable individuals. Backed by venture capital firm Antler, Gladys is poised to redefine social care, empowering caregivers and families. | $2M | Seed | Oct 13, 2025 |  |
| Unfabled | Unfabled is a women’s health consumer platform that delivers curated and personalised solutions. | $1.7M | Seed | Oct 13, 2025 |  |
| Open Health Technologies | Open Health Technologies provides FHIR-based lab and medical data integration with API delivery, form design, orchestration, and dashboards. | $3M | Seed | Sep 11, 2025 |  |
| Sava Technology | All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way. | $18.8M | Series A | Jul 30, 2025 |  |
| Alba Health | Alba Health is a wellness product. It is not intended to diagnose or treat disease, and it is not a substitute for medical advice. | $2.5M | Seed | May 27, 2025 |  |
| ReportAId | ReportAId is a artificial intelligence company that provides health data for medical reports that is used by patients, doctors, hospitals. | $2.5M | Pre-Seed | May 06, 2025 |  |
| Level Zero Health | Level Zero Health focuses on advanced biosensor technology to collect new types of data by combining biochemistry and nanotechnology. | $6.9M | Pre-Seed | Feb 18, 2025 |  |
| Jove Insurance | Jove is an insurtech company to provide flexible bundled insurance for contractors and freelancers | $4.5M | Seed | Nov 29, 2024 |  |

10 of 38 investments shown.

## Co-investors
- [2100 Ventures](https://shizune.co/investors/profile/2100-ventures) — VC Fund, 3 deals together
- [Cornerstone VC](https://shizune.co/investors/profile/cornerstone-vc) — VC Fund, 3 deals together
- [Heartfelt Capital](https://shizune.co/investors/profile/heartfelt-capital) — VC Fund, 3 deals together
- [NewAlpha Asset Management VC](https://shizune.co/investors/profile/newalpha-asset-management) — VC Fund, 3 deals together
- [Unruly Capital](https://shizune.co/investors/profile/unruly-capital) — VC Fund, 3 deals together
- [Angel Academe](https://shizune.co/investors/profile/angel-academe) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Food and Beverage VC Funds in Germany](https://shizune.co/investors/food-and-beverage-vc-funds-germany)
- [Biotechnology VC Funds in Germany](https://shizune.co/investors/biotechnology-vc-funds-germany)
- [Biotech VC Funds in Germany](https://shizune.co/investors/biotech-vc-funds-germany)
- [Venture Capital VC Funds in United Kingdom](https://shizune.co/investors/venture-capital-vc-funds-united-kingdom)
- [Recruiting VC Funds in United Kingdom](https://shizune.co/investors/recruiting-vc-funds-united-kingdom)
- [Medical VC Funds in Italy](https://shizune.co/investors/medical-vc-funds-italy)

## FAQ

### What does Exceptional Ventures invest in?

Exceptional Ventures invests primarily in Health Care, Biotechnology and Wellness startups, most often at Seed and Pre-Seed stage. Most of the 38 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Exceptional Ventures's check size?

Exceptional Ventures typically joins rounds of $1.6M–$5.3M at Seed, $641k–$6.9M at Pre-Seed and $1.3M–$3.7M at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Exceptional Ventures participates in.

### How do I contact Exceptional Ventures?

Public channels for Exceptional Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Exceptional Ventures?

The team at Exceptional Ventures includes Matt Cooper (Co-Founder and Executive Chairman) and Paolo Pio (Co-Founder and General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co